CYBB and type 2 diabetes mellitus: Meanwhile, a pilot study measuring the blood levels of soluble NADPH oxidase 2 (NOX2)-derived peptide, which is a marker of NOX2 activation and hydrogen peroxide production in patients with T2DM, showed that SGLT2i significantly reduced the level of both markers [15].